hDMT partner Minacned

About hDMT

The Institute for human Organ and Disease Model technologies (hDMT) is a precompetitive non-profit technological R&D institute, initiated in the Netherlands. hDMT integrates state-of-the-art human stem cell technologies with top level engineering, physics, chemistry, biology, clinical and pharmaceutical expertise from academia and industry to develop and valorize human organ and disease models-on-a-chip.

Human test model systems

These miniature models in chip format closely mimic human tissue and organs in vivo. This will primarily meet the need for representative human test model systems for drug development and other applications, and as an additional goal also will reduce the use of animal experiments. hDMT will engage in close dialogue with pharmaceutical and other companies to tune the scientific program to their needs for specific organ and disease models. Within the hDMT Institute also the ‘scalability and manufacturability’ of the technologies will be addressed.

Virtual institute

hDMT combines technologies, facilities and expertise from different disciplines and multiple organizations and locations, thereby forming a virtual institute, ‘a laboratory without walls’. hDMT is a public-private consortium of 9 founding partners, including the three Universities of Technology (Twente, Eindhoven, Delft), the Leiden University and University Medical Centre, Erasmus Medical Centre, the Hubrecht Institute, and two companies Genmab and Galapagos. As a central point of contact hDMT is envisaged as the gateway for pharmaceutical companies to ‘Organ on chip’ technology in the Netherlands, supported by world class stem cell science. hDMT will consolidate expertise in the Netherlands and collaborate with experts from abroad in this area to develop complementary international programs that will lead to new insights in human disease, and to new treatments and diagnostic tests.

Contact

hDMT
If you have any practical questions regarding hDMT, please send an e-mail: info@hdmt.technology.
For all other questions contact Managing Director Janny van den Eijnden – van Raaij: j.vandeneijnden@hdmt.technology or call +31(0)6 1299 8074.

Gepubliceerde artikelen

EUREKA Subsidie zoekt voorstellen voor waterstof innovaties

Tot en met 4 november 2021 is het mogelijk om voorstellen in…
7 oktober 2021/door Aurélie Veltema

Invest-NL investeert in Delft IMP

Invest-NL neemt voor € 5 miljoen deel in een investeringsronde…
6 oktober 2021/door Aurélie Veltema

Maser Engineering en Eurofins Scientific bundelen krachten

MASER Engineering, het technologisch toonaangevende testcentrum…
5 oktober 2021/door Aurélie Veltema

MinacNed presenteert: Micro Nano Sympsosia

In 2021 en 2022 organiseert MinacNed pre-events in de aanloop…
28 september 2021/door Aurélie Veltema

Koningin Máxima opent supercomputer voor Nederlandse wetenschap

Koningin Maxima 'opent' supercomputer (credits: Vera…
23 september 2021/door Aurélie Veltema

Video case VIRAPOC, de toekomst in virusdiagnostiek

Het VIRAPOC-project betreft de ontwikkeling van een lab-on-a-chip…
21 september 2021/door Aurélie Veltema

Matchmaking NWA safety assessment via animal-free models

Met dit online matchmaking platform brengen we verschillende…
14 september 2021/door Aurélie Veltema

NWO Spinoza premie voor Lieven Vandersypen

Professor Lieven Vandersypen (Foto: Studio Oostrum)

NWO heeft…
10 september 2021/door Aurélie Veltema

De international MicroNanoConference 2021 is geannuleerd

De international MicroNanoConference is de conferentie van MinacNed…
9 september 2021/door Aurélie Veltema

Nieuwe NWO subsidie instrumenten beschikbaar

Vergrijzing, diabetes type 2, tekort aan zorgpersoneel; onze…
8 september 2021/door Aurélie Veltema

Nikon opent eerste Europese Nikon BioImaging Lab op Leiden Bio Science Park

Amsterdam, Nederland, 24 Augustus 2021 – Nikon Europe B.V. heeft…
24 augustus 2021/door Aurélie Veltema

IamFluidics: Nieuwe ontwikkelingen in farmaceutisch onderzoek

Het ontwikkelen van hoogwaardige microdeeltjes om disruptieve…
24 augustus 2021/door Aurélie Veltema